We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Expects Companion Rx/Dx Guidance Within a Few Weeks
FDA Expects Companion Rx/Dx Guidance Within a Few Weeks
July 8, 2011
In the next two to three weeks, the FDA will be issuing guidance on labeling and development of combination diagnostic-therapeutic products, known as companion diagnostics, an FDA official said.